You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Localization and Evaluation of Sentinel Lymph Node in Breast Cancer From Computed Tomographic Lymphography

Tan, Hongna PhD*†; Yang, Benlong MD†‡; Wu, Jiong MD†‡; Wana, Shengping PhD*†; Gu, Yajia MD*†; Li, Wentao MD*†; Jiang, Zhaoxia PhD*†; Qian, Min BS*†; Peng, Weijun MD*†

Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e318213ccd9
Breast Imaging

Objective: This study aimed to determine the accuracy of computed tomographic (CT) localization and CT-based diagnosis of sentinel lymph nodes (SLNs) metastasis.

Methods: Thirty-four patients with confirmed breast cancer underwent 40-row CT scanning, and the first one or several lymph node(s) in the lymphatic drainage pathway was/were defined as the SLN(s). Dye and γ probe-guided SLN biopsy was performed on all patients. To accurately localize the SLN, 19 patients (55.9%) underwent the percutaneous lymph node puncture procedure. The morphologic features of all the SLNs on CT scans were analyzed and compared with the SLN biopsy pathologic diagnosis.

Results: Sentinel lymph nodes were successfully identified for all patients without any significant adverse effects. All localized SLNs corresponded well with SLNs identified on SLN biopsy, with an accuracy of 89.5%. Accuracy increased to 100% when the CT scan technique was combined with the blue dye method. The size criteria for metastatic diagnosis had a sensitivity of 85%, which increased to 94.7% when long-to-short-axis ratio and margin characteristics were also considered.

Conclusions: The CT lymphography combined with the blue dye method accurately localized the SLNs. The CT-based diagnostic criteria improved the diagnostic accuracy of SLN metastases and were useful for evaluating the axillary status in early stage breast cancer patients.

Author Information

From the Departments of *Radiology, and †Breast Surgery, Cancer Hospital/Institute, and ‡Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Received for publication November 22, 2010; accepted February 2, 2011.

Reprints: Weijun Peng, MD, Department of Radiology, Cancer Hospital/Cancer Institute and Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Rd, Shanghai 200032, China (e-mail:

© 2011 Lippincott Williams & Wilkins, Inc.